Centers for Medicare & Medicaid Services has proposed a near zero increase in Medicare Advantage payments, affecting growth ...
Medicare Advantage members in value-based care arrangements had 24.3% fewer inpatient hospital admissions than those in Original Medicare in 2024. Humana Medicare Advantage members receiving ...
Morgan Stanley flagged a new Medicare Advantage policy overhang, saying Humana’s "disproportionate" exposure could pressure ...
A federal proposal targeting Medicare Advantage payments sent Louisville-based Humana’s stock down about 20% Tuesday and ...
Shares of large Medicare plan providers Humana, CVS Health and UnitedHealth Group plunged in extended trading.
On October 14, 2025, Humana faced a legal setback when U.S. District Judge Reed O’Connor ruled against the company in its challenge to the Medicare Advantage Star Ratings. The Centers for Medicare & ...
Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...
That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.
Humana Inc. (NYSE:HUM) is one of the noteworthy S&P 500 stocks Jim Cramer highlighted. Cramer highlighted what caused an instant sell-off in companies like Humana and others that had exposure to ...
Humana is one of the many Medicare-approved private insurance companies that offer Medicare Advantage (Part C) plans. These plans are an alternative to Original Medicare (Part A and Part B) plans.
The healthcare sector, led by insurance stocks, has faced chronic underperformance since 2020 as premiums fail to keep up with costs. Humana has faced significant pressures, losing over 30% of its ...